Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 6 | 2022 | 2303 | 1.020 |
Why?
|
| Infectious Disease Medicine | 1 | 2020 | 3 | 0.750 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 215 | 0.700 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 39 | 0.690 |
Why?
|
| Medication Adherence | 1 | 2021 | 179 | 0.650 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 121 | 0.650 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 420 | 0.560 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 494 | 0.530 |
Why?
|
| Minority Groups | 1 | 2020 | 596 | 0.520 |
Why?
|
| Tennessee | 3 | 2022 | 70 | 0.410 |
Why?
|
| Viral Load | 2 | 2021 | 312 | 0.330 |
Why?
|
| Humans | 11 | 2022 | 37093 | 0.220 |
Why?
|
| Transsexualism | 1 | 2021 | 19 | 0.200 |
Why?
|
| Achievement | 1 | 2020 | 24 | 0.190 |
Why?
|
| History, 21st Century | 1 | 2020 | 81 | 0.180 |
Why?
|
| Societies, Medical | 1 | 2020 | 66 | 0.180 |
Why?
|
| Hydrocortisone | 1 | 2021 | 78 | 0.180 |
Why?
|
| History, 20th Century | 1 | 2020 | 117 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 61 | 0.170 |
Why?
|
| Hepatitis C | 1 | 2019 | 125 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 441 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2019 | 157 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2021 | 661 | 0.160 |
Why?
|
| Male | 4 | 2021 | 20025 | 0.150 |
Why?
|
| Poverty | 1 | 2020 | 348 | 0.150 |
Why?
|
| Adolescent | 4 | 2022 | 5363 | 0.150 |
Why?
|
| Young Adult | 3 | 2022 | 4268 | 0.140 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 560 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2020 | 642 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2026 | 0.120 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 262 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 277 | 0.100 |
Why?
|
| Adult | 4 | 2022 | 11712 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2022 | 286 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 109 | 0.100 |
Why?
|
| Risk Factors | 1 | 2019 | 3562 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 336 | 0.100 |
Why?
|
| United States | 1 | 2020 | 4223 | 0.090 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2008 | 11 | 0.080 |
Why?
|
| Measles | 1 | 2008 | 7 | 0.080 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 72 | 0.080 |
Why?
|
| Aged | 1 | 2019 | 6741 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2008 | 103 | 0.070 |
Why?
|
| HIV Seropositivity | 1 | 2008 | 190 | 0.070 |
Why?
|
| Female | 4 | 2021 | 20969 | 0.070 |
Why?
|
| Meningitis, Bacterial | 1 | 2006 | 9 | 0.070 |
Why?
|
| Salmonella | 1 | 2006 | 11 | 0.070 |
Why?
|
| Salmonella Infections | 1 | 2006 | 17 | 0.070 |
Why?
|
| Middle Aged | 1 | 2019 | 10129 | 0.070 |
Why?
|
| Child | 2 | 2022 | 3131 | 0.060 |
Why?
|
| Infant | 2 | 2022 | 1046 | 0.060 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 7 | 0.050 |
Why?
|
| Case Management | 1 | 2021 | 20 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 94 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2022 | 1369 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 1418 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2016 | 127 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 623 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1455 | 0.020 |
Why?
|
| Ceftriaxone | 1 | 2006 | 7 | 0.020 |
Why?
|
| Seizures | 1 | 2006 | 68 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 1549 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 352 | 0.010 |
Why?
|